The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
POINT Biopharma Global Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q3 2023.
POINT Biopharma Global Inc. Operating Margin for the quarter ending September 30, 2023 was 44.2 %.
Operating Margin, Quarterly (%)
Period
Value
YoY Chg
Change %
Start Date
End Date
Q3 2023
44.2
Jul 1, 2023
Sep 30, 2023
Q2 2023
46.8
Apr 1, 2023
Jun 30, 2023
Q1 2023
50.6
Jan 1, 2023
Mar 31, 2023
Q4 2022
55.4
Oct 1, 2022
Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.